Kensey Nash announced that it has acquired the assets including the product lines of Synthes' Norian subsidiary for $22 million in cash, according to a Kensey Nash news release.
Norian currently manufactures orthobiosurgery products that are exclusively distributed by Synthes. As part of the companies' long-term supply agreement, Kensey Nash will manufacture Norian products and Synthes will exclusively distribute them. The companies also signed a research and development agreement to create certain related future products.
Also, manufacturing of the Norian product will move from a Synthes facility in West Chester, Pa., to a Kensey Nash facility in Exton, Pa., over 18-24 months.
Read the release report on the acquisition of Synthes subsidiary.
Related Articles on Synthes:
Johnson & Johnson's Synthes Takeover May Spur More Orthopedic Deals
Johnson & Johnson to Acquire Synthes for $21.3B
Johnson & Johnson Shareholders Uphold Use of Animals in Surgery